What is LENZ Therapeutics, Inc. Common Stock's Market Cap?

LENZ Therapeutics, Inc. Common Stock's Market Cap is $167.5M, based on as-reported figures from SEC (XBRL) filings.

What is LENZ Therapeutics, Inc. Common Stock's Enterprise Value?

LENZ Therapeutics, Inc. Common Stock's Enterprise Value is $143.3M, based on as-reported figures from SEC (XBRL) filings.

What is LENZ Therapeutics, Inc. Common Stock's Price / Sales?

LENZ Therapeutics, Inc. Common Stock's Price / Sales is 7.8×, based on as-reported figures from SEC (XBRL) filings.

What is LENZ Therapeutics, Inc. Common Stock's EV / Revenue?

LENZ Therapeutics, Inc. Common Stock's EV / Revenue is 6.7×, based on as-reported figures from SEC (XBRL) filings.

What is LENZ Therapeutics, Inc. Common Stock's EV / EBITDA?

LENZ Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is LENZ Therapeutics, Inc. Common Stock's Revenue (TTM)?

LENZ Therapeutics, Inc. Common Stock's Revenue (TTM) is $21.5M, based on as-reported figures from SEC (XBRL) filings.

What is LENZ Therapeutics, Inc. Common Stock's Net Income (TTM)?

LENZ Therapeutics, Inc. Common Stock's Net Income (TTM) is -$126.0M, based on as-reported figures from SEC (XBRL) filings.

What is LENZ Therapeutics, Inc. Common Stock's EBITDA?

LENZ Therapeutics, Inc. Common Stock's EBITDA is -$135.2M, based on as-reported figures from SEC (XBRL) filings.

What is LENZ Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

LENZ Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -4.01, based on as-reported figures from SEC (XBRL) filings.

What is LENZ Therapeutics, Inc. Common Stock's EBITDA Margin?

LENZ Therapeutics, Inc. Common Stock's EBITDA Margin is -629.6%, based on as-reported figures from SEC (XBRL) filings.

LENZ Therapeutics, Inc. Common Stock (LENZ) Financial Statements

LENZ Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00XDH4P05

XNAS · usd

5.33▼ 0.63 (-10.57%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close5.96

Day's Range5.32 – 5.95

52-Week Range4.54 – 50.40

Volume640.7K

Avg Volume720.4K

Share Statistics

Shares Outstanding

Employees152

ExchangeXNAS

Listed2024-03-22

Share count as of August 5, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about LENZ Therapeutics, Inc. Common Stock (LENZ)

What is LENZ Therapeutics, Inc. Common Stock's Market Cap?: LENZ Therapeutics, Inc. Common Stock's Market Cap is $167.5M, based on as-reported figures from SEC (XBRL) filings.
What is LENZ Therapeutics, Inc. Common Stock's Enterprise Value?: LENZ Therapeutics, Inc. Common Stock's Enterprise Value is $143.3M, based on as-reported figures from SEC (XBRL) filings.
What is LENZ Therapeutics, Inc. Common Stock's Price / Sales?: LENZ Therapeutics, Inc. Common Stock's Price / Sales is 7.8×, based on as-reported figures from SEC (XBRL) filings.
What is LENZ Therapeutics, Inc. Common Stock's EV / Revenue?: LENZ Therapeutics, Inc. Common Stock's EV / Revenue is 6.7×, based on as-reported figures from SEC (XBRL) filings.
What is LENZ Therapeutics, Inc. Common Stock's EV / EBITDA?: LENZ Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is LENZ Therapeutics, Inc. Common Stock's Revenue (TTM)?: LENZ Therapeutics, Inc. Common Stock's Revenue (TTM) is $21.5M, based on as-reported figures from SEC (XBRL) filings.
What is LENZ Therapeutics, Inc. Common Stock's Net Income (TTM)?: LENZ Therapeutics, Inc. Common Stock's Net Income (TTM) is -$126.0M, based on as-reported figures from SEC (XBRL) filings.
What is LENZ Therapeutics, Inc. Common Stock's EBITDA?: LENZ Therapeutics, Inc. Common Stock's EBITDA is -$135.2M, based on as-reported figures from SEC (XBRL) filings.
What is LENZ Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: LENZ Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -4.01, based on as-reported figures from SEC (XBRL) filings.
What is LENZ Therapeutics, Inc. Common Stock's EBITDA Margin?: LENZ Therapeutics, Inc. Common Stock's EBITDA Margin is -629.6%, based on as-reported figures from SEC (XBRL) filings.